** Shares of Australia's Tetratherix TTX.AX rise as much as 15.3% to A$3.320 on trading debut, compared with their IPO offer price of A$2.88 per share
** Firm lists on the ASX to accelerate development of its polymer platform technology, Tetramatrix
** Co raised A$25 million ($16.33 million) in its IPO, valuing it at A$145 million
** TTX has developed a proprietary fluid matrix that is invisible to the body and does not induce any foreign bodily reaction to evolve regenerative medicine and targeted therapeutic delivery
** TTX shares pare early surge to climb 0.7% at A$2.90, compared with 0.4% gain in the ASX200 benchmark index .AXJO
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.